bf/NASDAQ:LEGN_icon.jpeg

NASDAQ:LEGN

Legend Biotech

  • Stock

USD

Last Close

32.37

06/11 21:00

Market Cap

8.63B

Beta: −0.08

Volume Today

521.83K

Avg: 810.09K

PE Ratio

−39.80

PFCF: −29.36

    Description

    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comp...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1-0.50.52019-06-302020-11-162022-06-012023-11-202024-09-20

    Revenue (Estimate*)

    50M100M150M2019-06-302020-11-162022-06-012023-11-202024-09-20

    *Estimate based on analyst consensus